-
Antibody production
The 5 Pillars of Excellence in Stable Cell Line Development
In the rapidly evolving biopharmaceutical industry, stable cell line development (CLD) is the cornerstone of successful therapeutic protein production. Researchers and biomanufacturers alike seek high-quality, stable cell lines that provide…
-
Custom Antibody
Antibody Humanization Techniques
Read more -
Custom Antibody
The Essentials of Antibody Engineering
Read more -
Antibody production
How advanced monoclonal antibody generation methods are improving conventional envenoming treatments
Read more -
Antibody production
The Evolution of Antibody Production
Read more -
Antibody production
Harness the Power of Single B Cell Antibody Technologies for Advanced Antibody Development
Read more
-
Customers success stories
The Path of Creating an Innovative IL-17A Antibody for Autoimmune Disorders
Read more -
Antibody production
Polyclonal vs. Monoclonal antibodies: How to choose the best option for your project?
Read more -
Antibody production
How to choose the best antibody generation technique for your project?
Read more -
Antibody production
The best CHO expression system kits on the market
Read more -
Antibody production
A guide on how to easily transition to a new antibody expression system kit
Read more
-
Antibody production
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists” – Interview with Dr. Louisa James (QMUL)
Read more -
Antibody production
Reinventing IgY biotherapeutics – interview with Dr. Mara Freire (CICECO, University of Aveiro, Portugal)
Read more -
Antibody production
How the environment shapes immune system development during pregnancy – interview with Dr. Melanie Conrad
Read more -
Antibody production
“Cell-based phage display is helping us isolate more biologically relevant antibodies” – Interview with Dr. Mohamed Alfaleh (King Abdulaziz University)
Read more -
Antibody production
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation” – Interview with Prof. Tomáš Kalina (Charles University in Prague)
Read more